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Autoimmune diseases are chronic, frequent-
ly life-threatening conditions that strike
when the immune system goes awry and
attacks the body’s own tissues. Although
some autoimmune diseases—such as
rheumatoid arthritis, multiple sclerosis, and
systemic lupus erythematosus (SLE)—are
relatively common, many of the more than
80 identified diseases are rare. However,
overall, autoimmune diseases are the third
most common group of diseases in the
United States; they affect an estimated
14–22 million Americans and are responsi-
ble for significant morbidity, mortality, and
health care expenditures. Many strike
women and minority populations dispro-
portionately. For example, 85% of SLE
patients are female, and minorities have a
two- to threefold greater risk of developing
the disease. 
Although genetic pre-
dispositions have been
clearly implicated as major
risk factors for many of
these diseases, experts esti-
mate that such factors
account for only about one-
third of the risk. Today, a
great deal of research atten-
tion is focused on the high-
ly complex and thus far
poorly understood interac-
tions between environmen-
tal exposures and genetic
predisposition that appear
to contribute to the onset
of autoimmune diseases. 
Over 4–5 February
2003, a diverse group of
basic scientists, epidemiolo-
gists, clinicians, and other
researchers gathered in
Durham, North Carolina,
for “Environmental Factors
in Autoimmune Disease,” a
workshop designed to
assess the current state of
the knowledge on autoim-
mune diseases, and to
make recommendations on
goals for future research
initiatives. The workshop was sponsored
by the American Autoimmune Related
Diseases Association along with a variety
of governmental agencies—the NIEHS,
the NIH Offices of Rare Diseases and
Research on Women’s Health, the
National Health and Environmental
Effects Research Laboratory of the U.S.
Environmental Protection Agency, the
National Institute of Allergy and
Infectious Diseases, and the National
Institute of Arthritis and Musculoskeletal
and Skin Diseases.
This workshop was a follow-up to the
NIEHS’s initial meeting in the field, held
in September 1998. The thrust of that ses-
sion was to determine whether there was in
fact an identifiable link between environ-
mental exposures and autoimmune dis-
eases. Now the search is on to discover
which agents may play a role in which dis-
eases, how gene–environment interactions
result in the onset of autoimmune diseases,
and ultimately how these devastating con-
ditions might be prevented, ameliorated,
and eventually cured. 
Following the 1998 meeting, the
NIEHS awarded seven grants to study the
role of environmental factors in autoim-
mune diseases. This year’s workshop was
originally intended to be a meeting of
those grantees, whose projects were com-
pleted in late 2002. As interest in the
workshop grew, it expanded into a more
comprehensive opportunity to assess
progress in the field and identify research
goals across the disciplines involved.
Grants Grow Research Understanding
Day one of the workshop was devoted to
scientific presentations from the NIEHS
grantees and other leading experts in the
field. According to Pat Mastin, an extra-
mural program administrator with the
NIEHS and the chief organizer of the con-
ference, not all of the grant results were
what researchers were expecting, “but
sometimes what you find is more interest-
ing than what you go looking for. Each of
the grantees advanced the state of our
knowledge in this critical area.” 
NIEHS epidemiologist Glinda Cooper
reported on the state of the science in the
epidemiology of autoimmune diseases.
After familiarizing the attendees with the
latest information regarding the incidence,
prevalence, demographics, and trends
associated with autoimmune diseases, she
identified several future epidemiologic
research opportunities. Cooper particularly
emphasized the need for epidemiologic
studies of the prevalence of autoantibodies,
which, as possible markers of subclinical
disease, could shed light on the pathways
by which environmental exposures trigger
abnormal immune responses. 
Traditionally, autoimmune diseases
have been identified as diseases that are
systemic or those that are organ-specific.
Fred Miller, head of the NIEHS
Environmental Autoimmunity Group,
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The Environment–Autoimmune Linkpresented a thought-provoking case for a
more refined paradigm that he termed
“elemental disorders” to approach the
study of these diseases. He suggested that
many of the autoimmune diseases as they
are understood today are actually com-
posed of a variety of elemental disorders,
each of which is a unique syndrome with a
unique pathogenesis resulting from the
interaction of certain genetic and environ-
mental risk factors. 
To illustrate his proposed approach,
Miller cited the example of myositis.
Depending on which of the myositis-spe-
cific autoantibodies is involved, myositis
can clinically manifest in three distinct
ways, each with its own identifiable symp-
toms, prognoses, and therapies. Miller
considers these to be unique syndromes, or
elemental disorders, and suggests that by
not accounting for this characteristic of
several of the autoimmune diseases, much
of the research is being confounded.
Michael Pollard, an associate professor
of molecular and experimental medicine at
The Scripps Research Institute in La Jolla,
California, presented his work investigat-
ing the immunology and genetics of
murine mercury-induced autoimmunity.
His studies in knockout mice have shown
a clear dose–response relationship, with
animals receiving the highest dose of mer-
cury producing the most antibodies. This
suggests that mercury accelerates disease in
genetically susceptible populations. Pollard
has identified several potential pathways of
mercury-induced autoimmunity.
Noel Rose, director of the Johns
Hopkins Center for Autoimmune Disease
Research, discussed his work with mouse
models of varying genetic susceptibility to
myocarditis, an autoimmune disease that is
a major cause of heart failure. His data sug-
gest that although the disorder is induced
by a viral infection, there are clearly envi-
ronmental influences—in this case, lipo-
polysaccharides—that can exacerbate the
disease or increase susceptibility. Rose
believes that environmental exposures can
modify the immune response, triggering
autoimmune diseases in individuals with
genetic susceptibility, often in concert with
infectious agents.
Addressing the issue of imbalance in
autoimmune disease prevalence between the
sexes, Virginia Rider, an associate professor
of biology at Pittsburg State University in
Kansas, presented evidence that environ-
mental factors could play a role in sexual
dimorphism and autoimmunity. In in vitro
studies, she has identified pathways by
which estrogen metabolites could activate
human lymphocytes from patients with
SLE, causing an autoimmune response.
Exposure to environmental estrogens from
sources such as food animals, pesticides,
industrial by-products, and plants (some of
which produce phytoestrogens, compounds
similar to human estrogens) could also play
a role in triggering an autoimmune response
in susceptible people.
Denise Faustman, director of immuno-
biology at Boston’s Massachusetts General
Hospital, presented a modified paradigm
that suggests that environmental factors
could be responsible for modifying the nor-
mal immune response mainly at the level of
protein expression—that is, downstream of
the genes themselves. Posttranscriptional
modifications would account for the unex-
pectedly low concordance of autoimmune
diseases among identical twins, suggesting
that to a great extent there is a protein–envi-
ronment interaction occurring, as opposed
to a strictly gene–environment interaction.
She also asserted that protein defects could
represent a worthwhile target for treatment
of autoimmune diseases.
Two grantees investigated the process
of apoptosis in keeping the immune system
in check. Michael McCabe, an assistant
professor of environmental medicine at the
University of Rochester, presented data
suggesting that mercury exposure can inter-
fere with the complex assemblage of mole-
cules involved in apoptosis. Reduction or
curtailment of apoptosis can lead to an
autoimmune response. Shyr-Te Ju, a pro-
fessor of internal medicine at the University
of Virginia School of Medicine, has
approached the question of apoptosis by
developing transgenic mice that underpro-
duce IL-2 (one of the most important acti-
vating factors in the immune response) and
fas (a protein necessary for apoptosis). He
found that lacking these compounds did in
fact suppress apoptosis in his mice, and an
autoimmune response followed.
Two other grantees investigated
screening processes. Laurence Morel, an
assistant professor of rheumatology at the
University of Florida, worked with con-
genic mice having chromosomal regions
that confer SLE susceptibility. She exposed
these animals to estrogen and pristane. Her
results suggested that several different genes
could be involved in a gene–environment
effect. M. Eric Gershwin, chief of the
Division of Rheumatology, Allergy, and
Clinical Immunology at the University of
California, Davis, used the reverse approach.
He bred mice prone to primary biliary cir-
rhosis, an autoimmune disease that leads
to the destruction of the small bile ducts
in the liver. He then exposed these animals
to a spectrum of synthesized chemicals
designed to mimic lipoic acid, a molecule
implicated in the onset of the disease. The
idea was to determine whether the candi-
date compounds produced the highly dis-
ease-specific antimitochondrial antibodies
characteristic of the disease. Identifying
mimics of lipoic acid could shed light on
compounds in the environment that trig-
ger the disease.
Research by C. Lynne Burek, an assis-
tant professor of molecular microbiology
and immunology at The Johns Hopkins
University, with a mouse model of thy-
roiditis—the third most common autoim-
mune disease—showed “proof positive of
a gene–environment interaction,” accord-
ing to Mastin. Iodine was added to salt in
the 1920s to combat goiter resulting from
a lack of dietary iodine. In the decades
since, although goiter has all but disap-
peared, there has been a steady increase in
the incidence of thyroiditis, which might
stem from the ingestion of too much
iodine. Burek’s work suggests that the pro-
tein thyroglobulin may be the culprit
behind this association. 
Eric Sobel, an associate professor of
rheumatology and clinical immunology at
the University of Florida, studied the
effects of chlordecone, an organochlorine
pesticide, on the development of SLE in a
mouse model bred to be susceptible to the
disease. Upon exposure to chlordecone, the
mice showed autoimmune changes, as well
as specific clinical end points, particularly
renal damage, in dose–response fashion. It
was significant that these effects were
caused in a sensitive population not by a
metal—one of the few fairly reliable
“smoking guns” in this area of research and
the topic of many studies—but by a weak
exogenous estrogen.
Patricia Fraser, an assistant professor of
medicine at Harvard Medical School, was
the only grantee to focus on human popula-
tions. Her work on potential environmental
associations with SLE, particularly in the
African-American population, suggested that
sunlight and organic solvents may be indi-
vidual risk factors for SLE by interacting
with glutathione S-transferase genetic poly-
morphisms. Although it is more difficult to
show definitive gene–environment interac-
tions with human subjects than with a con-
trolled animal population, Fraser’s research
shows that increased risk can be quantified
in humans, suggesting a valuable methodol-
ogy for studies of human populations. 
Forward Focus
A report on the Autoimmune Diseases
Coordinating Committee research plan
(available at http://www.niaid.nih.gov/
dait/pdf/ADCC_Report.pdf) was present-
ed by Tom Esch, a program officer with
the National Institute of Allergy and
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agency effort was mandated by Congress to
coordinate research and educational efforts
in the area of autoimmune diseases. The
plan, which was intended to bring together
the various stakeholders in autoimmune
disease research—patients, the public, and
basic, preclinical, and clinical researchers—
included several references to the impor-
tance of assessing the role of environmental
factors in these diseases.
One important aspect of the workshop
was the results of six breakout sessions on
the topics of gene–environment interac-
tions, altered antigens, immune modula-
tions, signal transduction, and translational
research in both systemic and organ-specific
autoimmune diseases. Each breakout group
offered a variety of recommendations with-
in its subject, but broad areas of apparent
consensus also emerged from the proceed-
ings. Most consistently, the groups empha-
sized the need for improved collaboration.
The general feeling was that multidiscipli-
nary cross-institutional research initiatives
would do three things: help synthesize exist-
ing data by better integrating animal and
human studies, improve communication
among investigators, and focus future
research efforts more effectively as more
information emerges about the role of envi-
ronmental factors in autoimmune diseases. 
The other major point of agreement
among the groups was the need for transla-
tional research. As evidence that environ-
mental factors can play a critical role in the
onset or exacerbation of autoimmune dis-
eases continues to accumulate, the research
community needs to concentrate more effort
on the human application of its findings.
Specifically, the “bench-to-bedside” concept
of translational research holds the potential
to generate more and better biomarkers of
susceptibility, improved risk assessment, pre-
ventive measures for susceptible populations,
and, eventually, therapies designed to con-
trol or cure autoimmune diseases. 
“There is good reason to think that envi-
ronmental agents are involved in autoim-
mune diseases,” said Mastin. “Genetics
clearly isn’t the whole answer, and infectious
agents are clearly not the rest of the answer.
So it has to be something else, and natural-
ly, environmental exposures come to mind.”
Mastin said that autoimmune diseases are an
excellent area where translational research
can take place: “We have many clinical peo-
ple out there working on autoimmune dis-
eases, and if we can help them become more
cognizant of environmental factors, it will
go a long way toward approaching the ulti-
mate goal we all share—the treatment or
prevention of these debilitating and often
fatal diseases.” –Ernie Hood
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Headliners Gene–Environment Interaction
NIEHS-Supported Research
Effect of Polymorphisms on Biomarkers in Coal Miners
Nadif R, Jedlicka A, Mintz M, Bertrand J-P, Kleeberger S, Kauffmann F. 2003. Effect of
TNF and LTA polymorphisms on biological markers of response to oxidative stimuli in
coal miners: a model of gene-environment interaction. J Med Genet 40:96–103.
Genetic polymorphisms have been implicated in the difference in response to
environmental agents, but interactions between genes and environmental
oxidants involved in the development of human lung diseases have been
largely unexplored. Oxidative stress arising from cigarette smoking and long-
term exposure to dust and particles causes chronic airway inflammation,
which is essential to the development of many lung diseases such as asthma,
chronic obstructive pulmonary disease, and coal workers’ pneumoconiosis. In
a study of 253 coal miners in France, NIEHS grantee Steven Kleeberger and
colleagues investigated whether polymorphisms in two genes coding for the
proinflammatory cytokines tumor necrosis factor α (TNF) and lymphotoxin-α
(LTA) modify lung response to oxidants. 
Specifically, the researchers measured intermediate biomarkers of
response to oxidant exposure, including glutathione peroxidase (GSH-Px) and
catalase activity in red blood cells among miners genotyped for the two poly-
morphisms. The researchers also gathered detailed information on the work-
ers’ cumulative dust exposure and smoking habits. 
For miners with a promoter polymorphism at the –308 position in the
TNF gene, the researchers observed a significant association with red blood
cell GSH-Px activity at high oxidant exposure. No association was observed
among workers with this polymorphism who experienced low exposure.
Regarding clinical outcomes, the results showed a positive association for coal
workers’ pneumoconiosis among workers who had low catalase activity and
an NcoI polymorphism in the LTA gene. No association was seen in those with
high catalase activity, nor were any other significant associations observed. 
These results provide the first demonstration of the involvement of
genetic polymorphisms of two genes in the control of physiologic responses
to exposure to oxidative stressors. The study suggests an interaction of genetic
background with environmental exposure, and further suggests that interme-
diate responses are important in the development and progression of chronic
pulmonary diseases such as coal workers’ pneumoconiosis. –Jerry Phelps